We report a case of metastatic castration-resistant prostate cancer, who received prior treatment with docetaxel and was then given cabazitaxel as salvage therapy. The patient was monitored by prostate-specific antigen doubling time and prostate-specific antigen absolute value.
The prostate-specific antigen doubling time was found to be a good response predictor in the patient.
Journal of biomedical research. 2014 Mar 30 [Epub]
Marwan Ghosn, Alain Dagher, Fadi El-Karak
Hematology-Oncology Department, Faculty of Medicine, Saint-Joseph University , Beirut , Lebanon . , Hematology-Oncology Department, Faculty of Medicine, Saint-Joseph University , Beirut , Lebanon . , Hematology-Oncology Department, Faculty of Medicine, Saint-Joseph University , Beirut , Lebanon .